Stemmer Imaging AG
XETRA:S9I
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
27.9
56.8
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one S9I stock under the Base Case scenario is 55.76 EUR. Compared to the current market price of 56.8 EUR, Stemmer Imaging AG is Overvalued by 2%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Stemmer Imaging AG
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for S9I cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Stemmer Imaging AG
Balance Sheet Decomposition
Stemmer Imaging AG
Current Assets | 62.4m |
Cash & Short-Term Investments | 30.4m |
Receivables | 20.2m |
Other Current Assets | 11.9m |
Non-Current Assets | 32.3m |
Long-Term Investments | 209k |
PP&E | 5.2m |
Intangibles | 26.2m |
Other Non-Current Assets | 686k |
Current Liabilities | 20.8m |
Accounts Payable | 13.2m |
Short-Term Debt | 500k |
Other Current Liabilities | 7.1m |
Non-Current Liabilities | 6m |
Long-Term Debt | 4.2m |
Other Non-Current Liabilities | 1.8m |
Earnings Waterfall
Stemmer Imaging AG
Revenue
|
126.2m
EUR
|
Cost of Revenue
|
-75.9m
EUR
|
Gross Profit
|
50.3m
EUR
|
Operating Expenses
|
-33.4m
EUR
|
Operating Income
|
16.9m
EUR
|
Other Expenses
|
-4.8m
EUR
|
Net Income
|
12m
EUR
|
Free Cash Flow Analysis
Stemmer Imaging AG
EUR | |
Free Cash Flow | EUR |
Stemmer Imaging experienced a significant revenue drop to EUR 27.5 million in Q1 2024, down from EUR 40.4 million the previous year, mainly due to weak demand across all markets. However, strong cost management helped maintain the gross margin at 39.9%. The EBITDA margin slipped to 14.9%, below their guidance of 17%-21%, but recovery is expected by year-end. Optimistic about an upswing in the second half, the company projects a rebound driven by strong bookings, especially in medical, logistics, and entertainment sectors. They reaffirmed full-year revenue and EBITDA guidance, anticipating a resurgence in key end markets.
What is Earnings Call?
S9I Profitability Score
Profitability Due Diligence
Stemmer Imaging AG's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
Score
Stemmer Imaging AG's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
S9I Solvency Score
Solvency Due Diligence
Stemmer Imaging AG's solvency score is 96/100. The higher the solvency score, the more solvent the company is.
Score
Stemmer Imaging AG's solvency score is 96/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
S9I Price Targets Summary
Stemmer Imaging AG
According to Wall Street analysts, the average 1-year price target for S9I is 46.67 EUR with a low forecast of 36.36 EUR and a high forecast of 53.55 EUR.
Dividends
Current shareholder yield for S9I is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
S9I Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
STEMMER IMAGING AG engages in the distribution of machine vision products. The company is headquartered in Puchheim, Bayern and currently employs 333 full-time employees. The company went IPO on 2018-02-27. The firm's offering includes a complete technical range of products from a variety of manufacturers, such as cameras, lenses, illumination products, machine vision systems, as well as its own custom-made solutions, such as customized cables and protective housings for machine vision cameras. In addition, the Company develops imaging software, Common Vision Blox. The firm's machine vision solutions can be used in industrial automation to ensure quality control. Application areas include automotive, print, packaging, food and pharmaceutical industries, medical engineering and traffic technology, among others. The firm also provides customer support services, offering customized advice, feasibility studies and training, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one S9I stock under the Base Case scenario is 55.76 EUR.
Compared to the current market price of 56.8 EUR, Stemmer Imaging AG is Overvalued by 2%.